These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 23141909)
1. Design and synthesis of novel bis-thiazolone derivatives as micromolar CDC25 phosphatase inhibitors: effect of dimerisation on phosphatase inhibition. Sarkis M; Tran DN; Kolb S; Miteva MA; Villoutreix BO; Garbay C; Braud E Bioorg Med Chem Lett; 2012 Dec; 22(24):7345-50. PubMed ID: 23141909 [TBL] [Abstract][Full Text] [Related]
2. Development of novel thiazolopyrimidines as CDC25B phosphatase inhibitors. Kolb S; Mondésert O; Goddard ML; Jullien D; Villoutreix BO; Ducommun B; Garbay C; Braud E ChemMedChem; 2009 Apr; 4(4):633-48. PubMed ID: 19212959 [TBL] [Abstract][Full Text] [Related]
3. Discovery of new inhibitors of Cdc25B dual specificity phosphatases by structure-based virtual screening. Lavecchia A; Di Giovanni C; Pesapane A; Montuori N; Ragno P; Martucci NM; Masullo M; De Vendittis E; Novellino E J Med Chem; 2012 May; 55(9):4142-58. PubMed ID: 22524450 [TBL] [Abstract][Full Text] [Related]
4. Rapid discovery of triazolobenzylidene-thiazolopyrimidines (TBTP) as CDC25 phosphatase inhibitors by parallel click chemistry and in situ screening. Duval R; Kolb S; Braud E; Genest D; Garbay C J Comb Chem; 2009; 11(6):947-50. PubMed ID: 19835352 [No Abstract] [Full Text] [Related]
5. Synthesis of miltirone analogues as inhibitors of Cdc25 phosphatases. Huang W; Li J; Zhang W; Zhou Y; Xie C; Luo Y; Li Y; Wang J; Li J; Lu W Bioorg Med Chem Lett; 2006 Apr; 16(7):1905-8. PubMed ID: 16434190 [TBL] [Abstract][Full Text] [Related]
6. Effective Pharmacophore for CDC25 Phosphatases Enzyme Inhibitors: Newly Synthesized Bromothiazolopyrimidine Derivatives. El-Shahat M; Salama MAM; El-Farargy AF; Ali MM; Ahmed DM Mini Rev Med Chem; 2021; 21(1):118-131. PubMed ID: 32560601 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological evaluation and molecular modeling studies on novel quinonoid inhibitors of CDC25 phosphatases. Evain-Bana E; Schiavo L; Bour C; Lanfranchi DA; Berardozzi S; Ghirga F; Bagrel D; Botta B; Hanquet G; Mori M J Enzyme Inhib Med Chem; 2017 Dec; 32(1):113-118. PubMed ID: 27774816 [TBL] [Abstract][Full Text] [Related]
8. Novel naphthoquinone and quinolinedione inhibitors of CDC25 phosphatase activity with antiproliferative properties. Braud E; Goddard ML; Kolb S; Brun MP; Mondésert O; Quaranta M; Gresh N; Ducommun B; Garbay C Bioorg Med Chem; 2008 Oct; 16(19):9040-9. PubMed ID: 18789703 [TBL] [Abstract][Full Text] [Related]
9. Discovery of novel Cdc25 phosphatase inhibitors with micromolar activity based on the structure-based virtual screening. Park H; Bahn YJ; Jung SK; Jeong DG; Lee SH; Seo I; Yoon TS; Kim SJ; Ryu SE J Med Chem; 2008 Sep; 51(18):5533-41. PubMed ID: 18714978 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of novel naphthoquinone derivatives with CDC25 phosphatase inhibitory activity. Brun MP; Braud E; Angotti D; Mondésert O; Quaranta M; Montes M; Miteva M; Gresh N; Ducommun B; Garbay C Bioorg Med Chem; 2005 Aug; 13(16):4871-9. PubMed ID: 15921913 [TBL] [Abstract][Full Text] [Related]
11. Screening of indeno[1,2-b]indoloquinones by MALDI-MS: a new set of potential CDC25 phosphatase inhibitors brought to light. Alchab F; Sibille E; Ettouati L; Bana E; Bouaziz Z; Mularoni A; Monniot E; Bagrel D; Jose J; Le Borgne M; Chaimbault P J Enzyme Inhib Med Chem; 2016; 31(sup3):25-32. PubMed ID: 27362889 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel thiadiazole amides as potent Cdc25B and PTP1B inhibitors. Li Y; Yu Y; Jin K; Gao L; Luo T; Sheng L; Shao X; Li J Bioorg Med Chem Lett; 2014 Sep; 24(17):4125-8. PubMed ID: 25124112 [TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of macrocyclic inhibitors of phosphatase cdc25B. Bäurle S; Blume T; Günther J; Henschel D; Hillig RC; Husemann M; Mengel A; Parchmann C; Schmid E; Skuballa W Bioorg Med Chem Lett; 2004 Apr; 14(7):1673-7. PubMed ID: 15026048 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of Cdc25 phosphatases by indolyldihydroxyquinones. Sohn J; Kiburz B; Li Z; Deng L; Safi A; Pirrung MC; Rudolph J J Med Chem; 2003 Jun; 46(13):2580-8. PubMed ID: 12801222 [TBL] [Abstract][Full Text] [Related]
15. Computational design, synthesis and biological evaluation of para-quinone-based inhibitors for redox regulation of the dual-specificity phosphatase Cdc25B. Keinan S; Paquette WD; Skoko JJ; Beratan DN; Yang W; Shinde S; Johnston PA; Lazo JS; Wipf P Org Biomol Chem; 2008 Sep; 6(18):3256-63. PubMed ID: 18802630 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and functional evaluation of triazine-based bivalent agents that simultaneously target the active site and hot spot of phosphatase Cdc25B. Nagaoka Y; Parvatkar P; Hirai G; Ohkanda J Bioorg Med Chem Lett; 2021 Sep; 48():128265. PubMed ID: 34273487 [TBL] [Abstract][Full Text] [Related]
17. Discovery of potent and selective Cdc25 phosphatase inhibitors via rapid assembly and in situ screening of Quinonoid-focused libraries. Tao Y; Hao X; Jing L; Sun L; Cherukupalli S; Liu S; Wu G; Xu S; Zhang X; Shi X; Song Y; Liu X; Zhan P Bioorg Chem; 2021 Oct; 115():105254. PubMed ID: 34426152 [TBL] [Abstract][Full Text] [Related]
19. Structure-based de novo design and biochemical evaluation of novel Cdc25 phosphatase inhibitors. Park H; Bahn YJ; Ryu SE Bioorg Med Chem Lett; 2009 Aug; 19(15):4330-4. PubMed ID: 19497739 [TBL] [Abstract][Full Text] [Related]
20. Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors. Park H; Li M; Choi J; Cho H; Ham SW Bioorg Med Chem Lett; 2009 Aug; 19(15):4372-5. PubMed ID: 19500977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]